INTRODUCTION
While efficacy of antifibrotics (pirfenidone and nintedanib) in idiopathic pulmonary fibrosis (IPF) is well established, its effects on combined pulmonary fibrosis and emphysema (CPFE) remain unclear. We evaluated the therapeutic efficacy of antifibrotics in CPFE patients.
METHODS
This multicentre study...
H. Gwon, Jongmin Lee, Man Pyo Chung et al.· Archivos de Bronconeumologia· 1 citation
This updated guideline draws on evidence published over the past 5 years and covers the epidemiology, pathogenesis, risk factors, clinical manifestations, diagnosis, treatment, comorbidities, prognosis, and acute exacerbations of IPF.
H. Choi, Hee-Young Yoon, So Young Park et al.· Tuberculosis and Respiratory...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.